Showing results (2621-2630 of 9,654) with videos related to
Sort By:
Pageof 966
Leukemia|July 9, 2015
Blockade of BCL-2 proteins efficiently induces apoptosis in progenitor cells of high-risk myelodysplastic syndromes patientsS Jilg, V Reidel, C Müller-Thomas, et al.Leukemia|July 9, 2015
Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progressionA Mayado, C Teodosio, A C Garcia-Montero, et al.Leukemia|July 16, 2015
Aberrant expression of miR-9/9* in myeloid progenitors inhibits neutrophil differentiation by post-transcriptional regulation of ERGK Nowek, S M Sun, L Bullinger, et al.Leukemia|July 22, 2015
MMSET regulates expression of IRF4 in t(4;14) myeloma and its silencing potentiates the effect of bortezomibZ Xie, C Bi, J Y Chooi, et al.Leukemia|June 6, 2015
Deletion of Stat3 enhances myeloid cell expansion and increases the severity of myeloproliferative neoplasms in Jak2V617F knock-in miceD Yan, F Jobe, R E Hutchison, et al.Leukemia|June 9, 2015
BAALC potentiates oncogenic ERK pathway through interactions with MEKK1 and KLF4K Morita, Y Masamoto, K Kataoka, et al.Leukemia|June 9, 2015
IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951E Clappier, N Grardel, M Bakkus, et al.Leukemia|June 10, 2015
Identification of bromodomain-containing protein-4 as a novel marker and epigenetic target in mast cell leukemiaG Wedeh, S Cerny-Reiterer, G Eisenwort, et al.Leukemia|June 16, 2015
Differential PAX5 levels promote malignant B-cell infiltration, progression and drug resistance, and predict a poor prognosis in MCL patients independent of CCND1A E Teo, Z Chen, R N Miranda, et al.Leukemia|August 20, 2016
Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphomaK D Wurster, F Hummel, J Richter, et al.Pageof 966